Practice
Featured experience
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Azul $800 million secured notes offering
The senior secured notes are due 2028
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
NBCUniversal partnership with MultiChoice to relaunch Showmax using Peacock
We are advising NBCUniversal on the transaction to relaunch MultiChoice’s Showmax service using the Peacock platform
Davis Polk Advises SS&C on Its Acquisition of Intralinks
Davis Polk is advising SS&C Technologies Holdings, Inc. on its $1.5 billion acquisition of Intralinks Holdings, Inc…
Davis Polk Advises Ultra Clean Holdings, Inc. on Its Acquisition of Quantum Global Technologies, LLC and Related Financing
Davis Polk advised Ultra Clean Holdings, Inc. on its acquisition of Quantum Global Technologies, LLC (“QGT”) for $342…
Davis Polk Advises Tyson Foods on Its Acquisition of Keystone Foods
Davis Polk is advising Tyson Foods, Inc. on its $2.16 billion acquisition of the Keystone Foods business from Marfrig Global…
Davis Polk Advises Heineken on its Non-Binding Agreements with China Resources to Join Forces in China
Davis Polk is advising Heineken N.V. in connection with its non-binding agreements with China Resources Enterprise (“CRE”)…
Endava plc $145 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with an initial public offering of 7…
Davis Polk Advises Services Group of America on the Sale of Its Food Group of Companies to US Foods
Davis Polk is advising Services Group of America on the $1.8 billion sale of its five operating companies collectively known…
Davis Polk Advises Williams on the Sale of Williams Partners’ Four Corners Area Business to Harvest Midstream
Davis Polk is advising Williams on its $1.125 billion combined sale of assets and equity comprising Williams Partners L.P.’s…
MSCI sale of InvestorForce to Resurgens Technology Partners
Davis Polk is advising MSCI on its sale of InvestorForce to Resurgens Technology Partners. The transaction is expected to…
Bloom Energy Corporation Initial Public Offering
Davis Polk advised the underwriters in connection with an initial public offering of 18,000,000 shares of common stock of…
Constellation Pharmaceuticals Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with the $60 million initial public…